Holocene Advisors, LP Astrazeneca PLC Transaction History

Holocene Advisors, LP

$40.7 Billion
Q3 2025

A detailed history of Holocene Advisors, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Holocene Advisors, LP holds 6,129,194 shares of AZN stock, worth $548 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

6,129,194

Previous 4,321,629 41.83%

Holding current value

$548 Million

Previous $302 Million 55.71%

% of portfolio

1.15%

Previous 0.79%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $124 Million - $148 Million	1,807,565 Added 41.83%	6,129,194 $470 Million
Q2 2025 Aug 14, 2025	SELL	$64.87 - $75.0 $8.09 Million - $9.36 Million	-124,752 Reduced 2.81%	4,321,629 $302 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $9.54 Million - $11.4 Million	145,980 Added 3.39%	4,446,381 $327 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $272 Million - $342 Million	4,300,401 New	4,300,401 $282 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $197 Million - $238 Million	-2,944,348 Reduced 53.79%	2,529,024 $197 Million

Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $79.1 Million - $90.1 Million	1,295,279 Added 31.0%	5,473,372 $371 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $105 Million - $118 Million	1,702,482 Added 68.77%	4,178,093 $281 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $50.2 Million - $55.5 Million	774,722 Added 45.55%	2,475,611 $168 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $741,535 - $804,116	-10,607 Reduced 0.62%	1,700,889 $122 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $43.5 Million - $49.3 Million	-689,168 Reduced 28.71%	1,711,496 $119 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $16.4 Million - $21.2 Million	301,632 Added 14.37%	2,400,664 $163 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $18.9 Million - $48.3 Million	356,026 Added 20.43%	2,099,032 $115 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $103 Million - $124 Million	1,743,006 New	1,743,006 $115 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $62.1 Million - $73.4 Million	-1,149,393 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $15.5 Million - $17 Million	279,399 Added 32.12%	1,149,393 $69 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $14.5 Million - $18 Million	-299,187 Reduced 25.59%	869,994 $52.1 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $55.1 Million - $63.7 Million	1,169,181 New	1,169,181 $58.1 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $16.8 Million - $19.3 Million	-316,251 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $13.6 Million - $17.5 Million	316,251 New	316,251 $16.7 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $6.25 Million - $8.48 Million	-165,275 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $46.1 Million - $54.7 Million	-1,084,967 Reduced 86.78%	165,275 $8.24 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $29.6 Million - $33.5 Million	736,876 Added 143.54%	1,250,242 $55.7 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $19.1 Million - $21.4 Million	513,366 New	513,366 $21.2 Million

Others Institutions Holding AZN

# of Institutions

1,499

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Astrazeneca PLC Transaction History